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  Aberrant methylation of CpG islands is a common mechanism for tumor suppressor genes 
in a variety of human malignancies. The preproenkephalin (ppENK) gene encodes a native 
opioid peptide, met-enkephalin, which is known to be a potent regulator of development, cell 
proliferation and angiogenesis. ppENK hypermethylation is recognized in 90% in pancreatic 
carcinoma (PCa), but not normal pancreas tissues. We analyzed the ppENK hypermethylation in 
pure pancreatic juice (PPJ) in patients with PCa and chronic pancreatitis (CP), and elucidated 
the usefulness for diagnosis of PCa. Furthermore, p53 mutations were also studied in the same 
PCa patients.  
  PPJ was collected endoscopically from 28 patients with PCa and 20 patients with CP. DNA 
was extracted from PPJ. Methylation specific PCR was performed for hypermethylation 
analyses with the DNA extracted from these samples. In addition, single-strand conformation 
polymorphism and sequencing were performed simultaneously for the analyses of p53 
mutations. 
  The incidence of ppENK hypermethylation in PPJ was 50% (14 of 28) in patients with PCa. 
In contrast, only one of 20 cases presented hypermethylation in patients with CP (p＜0.002). 
p53 mutations were observed in 12 of 28 PCa cases (42.9%), but not in 20 CP cases. In 
combination analyses of ppENK hypermethylation and p53 mutations both were positive in 7 
and both were negative in 9 of 28 patients. ppENK hypermethylation alone was positive in 7 and 
p53 mutations alone in 5 patients. ppENK hypermethylation or p53 mutations were observed in 
19 of 28 shown in Table, so that positivity improved to 67.9% upon their combination. 
  These results suggest that ppENK hypermethylation in PPJ would be specific for cancer, 
and the combination assay with p53 could enhance the genetic diagnosis of PCa. 
 
 
           Table. Comparison of ppENK hypermethylation and p53  
                 mutations from patients with pancreatic cancer  
 
                                      p53 mutations           
                                       +       -      Total 
 
                 ppENK          +     7       7       14 
             hypermethylation      -     5       9       14 
                  
                  Total                12      16       28 
